MAGNI, PAOLO
MAGNI, PAOLO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Relevance of pre-analytical factors in multiomics: Toward a standardized blood processing protocol
2026 F. Trindade, M. Sopić, M.J. Davies, C. Tsatsanis, F. Pinet, H.B. Ferreira, J. Munjas, K.R. Mayilyan, M.M. Formosa, R. Attard, R. Farrugia, R. Vitorino, S. Khatib, S. Bezzina Wettinger, S. Novella, V. Kosek, Y. Sohrabi, P. Magni, Y. Devaux, D. de Gonzalo-Calvo, M. Mardal
Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease
2026 L.T. Nordestgaard, P. Magni, M. Sopić, M. Chemaly, L. Matic, N. Dalila, F. Trindade, B.N. Wolford, Z. Rodriguez-Hernandez, N. Amigó, A.L. Catapano, L. Masana, Y. Devaux
Pharmacological Effects of Angiotensin 1–7 on Venous Vascular Tone
2026 A. Daci, H. Berisha, E. Rexhbeqaj, I. Berisha, K. Zenuni, P. Magni
Toward Precision Medicine in Atherosclerotic Cardiovascular Disease: Insights from Omics Data into Sex Differences
2025 J. Munjas, S. Vladimirov, T. Ratkovic, L. Comi, C. Giglione, I. Tanaskovic, T. Gojkovic, B. Rakic, A. Davidovic, L. Vukmirovic, M. Milanov, D. Cvijanovic, P. Magni, M. Sopic
Neurofilament Light Chain Levels, Skeletal Muscle Loss, and Nutritional Decline: Key Prognostic Factors in Amyotrophic Lateral Sclerosis
2025 A. Zulueta, R. Piras, D. Azzolino, P. Mariani, R. Sideri, C. Garrè, G. Federico, T. Lucchi, P. Magni, E.A. Parati, C. Lunetta
An integrated view of the pathophysiological crosstalk between adipose tissue, bone and cardiovascular system in men and women
2025 F.T. Klinaku, L. Comi, C. Giglione, P. Magni
Multiomics in atherosclerotic cardiovascular disease
2025 L.T. Nordestgaard, B.N. Wolford, D. de Gonzalo-Calvo, M. Sopić, Y. Devaux, L. Matic, S.B. Wettinger, J.A. Schmid, N. Amigó, L. Masana, A.L. Catapano, D. Kardassis, P. Magni
Biological Sex and Cardiovascular Disease Prevention in Systemic Arterial Hypertension
2025 E. Gerdts, S. Novella, Y. Devaux, P. Magni, H. Marti, M. Sopić, G. Kararigas
Editorial: Multiomic approaches in atherosclerosis
2025 M. Sopić, T. Mitić, J. Sluimer, P. Magni, Y. Devaux
Current status and challenges of multi-omics research using animal models of atherosclerosis
2025 T. Mitić, A. Georgescu, N. Alexandru-Moise, M.J. Davies, C. Vindis, S. Novella, E. Gerdts, G. Kararigas, S.B. Wettinger, M.M. Formosa, B.R. Kwak, F. Molica, N. Amigo, A. Caporali, F. De La Cuesta, I.F. Hall, A. Chroni, F. Martelli, J.A. Schmid, P. Magni, D. Kardassis
Deciphering immune dynamics in atherosclerosis: Inflammatory mediators as biomarkers and therapeutic target
2025 P. Magni, T. Mitić, Y. Devaux, P. Pierre, M. Sopić, F. De La Cuesta, R. Vitorino
Unravelling molecular mechanisms in atherosclerosis using cellular models and omics technologies
2025 D. Kardassis, C. Vindis, C.S. Stancu, L. Toma, A.V. Gafencu, A. Georgescu, N. Alexandru-Moise, F. Molica, B.R. Kwak, A. Burlacu, I.F. Hall, E. Butoi, P. Magni, J. Wu, S. Novella, L.F. Gamon, M.J. Davies, A. Caporali, F. De La Cuesta, T. Mitić
Bottlenecks in advancing and applying multiomic data integration—common data resources as rate-limiting drivers—the high-impact use case of atherosclerotic cardiovascular disease
2025 S. Bezzina Wettinger, K. Karaduzovic-Hadziabdic, R. Attard, R. Farrugia, B.N. Wolford, M. Chierici, G. Jurman, P. Alexiou, J.L. Peñalvo, R.S. Costa, J. Basílio, F. Sabovčik, R. Vitorino, J.A. Schmid, R. Shigdel, B. Vilne, A.G. Hatzigeorgiou, M. Sopic, Y. Devaux, P. Magni, M. Tellez-Plaza, D.P. Kreil, A. Gruca
Advancing atherosclerosis research: The Power of lipid imaging with MALDI-MSI
2025 C.H.M. Bookmeyer, F.X. Correig, L. Masana, P. Magni, Ó. Yanes, M. Vinaixa
Triglycerides as Determinants of Global Lipoprotein Derangement: Implications for Cardiovascular Prevention
2025 N. Amigó, P. Torné, L.T. Nordestgaard, F. Di Giacomo-Barbagallo, C. Merino, P. Magni, A. González-Lleó, N. Andreychuk, A.L. Catapano, L. Masana, D. Ibarretxe
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
2025 L. Comi, C. Giglione, F.T. Klinaku, F. Pialorsi, V. Tollemeto, M. Zurlo, A. Seneci, P. Magni
Evaluation of Metabolic Dysfunction-Associated Fatty Liver Disease-Related Pathogenic Mechanisms in Human Steatotic Liver Cell-Based Model: Beneficial Effects of Prunus domestica L. subsp. syriaca Extract
2025 L. Comi, C. Giglione, F. Tolaj Klinaku, L. Da Dalt, H. Ullah, M. Daglia, P. Magni
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
2025 H. Berisha, R. Hattab, L. Comi, C. Giglione, S. Migliaccio, P. Magni
Efficacy of nutritional plant-based extracts from Aframomum citratum and Xylopia parviflora in mitigating epididymal and excrement fat accumulation in DIO-C57BL/6 mice
2025 A.P.N. Atchan, S.T.S. Murthy, P. Magni, F. Ferriere, G.A. Agbor, J. Kuiate, U.V. Manjappara
Impact of spaceflight on endocrine, metabolic and kidney function: current evidence, open issues, and potential countermeasures
2025 P. Magni, G. Ricci, M. Narici, F. Ferranti